Cambridge Investment Research Advisors, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$27.1 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 02, 2021	SELL	$10.93 - $23.55 $113,628 - $244,825	-10,396 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$10.0 - $14.52 $103,960 - $150,949	10,396 New	10,396 $134,000

Others Institutions Holding AUPH

# of Institutions

191

Shares Held

56.2M

Call Options Held

499K

Put Options Held

637K

Armistice Capital, LLC New York, NY

11.1M
Shares

$81.1 Million
0.83% of portfolio
Black Rock Inc. New York, NY

9.27M
Shares

$67.5 Million
0.0% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$28.9 Million
2.14% of portfolio
State Street Corp Boston, MA

2.88M
Shares

$21 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.78M
Shares

$20.2 Million
1.94% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account